"Olmesartan Medoxomil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.
| Descriptor ID |
D000068557
|
| MeSH Number(s) |
D03.383.129.308.674 D03.383.129.617.584
|
| Concept/Terms |
Olmesartan Medoxomil- Olmesartan Medoxomil
- Medoxomil, Olmesartan
- 5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346
|
Below are MeSH descriptors whose meaning is more general than "Olmesartan Medoxomil".
Below are MeSH descriptors whose meaning is more specific than "Olmesartan Medoxomil".
This graph shows the total number of publications written about "Olmesartan Medoxomil" by people in this website by year, and whether "Olmesartan Medoxomil" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Olmesartan Medoxomil" by people in Profiles.
-
Jinno T, Iwai M, Li Z, Li JM, Liu HW, Cui TX, Rakugi H, Ogihara T, Horiuchi M. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan. Hypertension. 2004 Feb; 43(2):263-9.
-
Liu HW, Iwai M, Takeda-Matsubara Y, Wu L, Li JM, Okumura M, Cui TX, Horiuchi M. Effect of estrogen and AT1 receptor blocker on neointima formation. Hypertension. 2002 Oct; 40(4):451-7; discussion 448-50.